High-Intensity Focused Ultrasound (HIFU) Therapy Applications

Ultrasound Clinics

Volumn 4, Issue 3, 2009, Pages 307-321

  Dogra, Vikram S ^a   Zhang, Man ^b   Bhatt, Shweta ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

HIFU; High intensity focused ultrasound; Therapy; Tumor; Ultrasound

Indexed keywords

BLADDER CANCER; BRAIN METASTASIS; BREAST CANCER; BREAST FIBROADENOMA; CATARACT; CLINICAL TRIAL; EYE TUMOR; FRACTURE HEALING; GLAUCOMA; HEMOSTASIS; HIGH INTENSITY FOCUSED ULTRASOUND; HISTORY; HUMAN; KIDNEY TUMOR; LIVER TUMOR; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RETINA DETACHMENT; REVIEW; ULTRASOUND THERAPY; ULTRASOUND TRANSDUCER; UTERUS MYOMA; VITREOUS HEMORRHAGE;

EID: 75849135829     PISSN: 1556858X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cult.2009.10.005     Document Type: Review

References (171)

1. Lele P.P. Application of ultrasound in medicine. N Engl J Med 286 24 (1972) 1317-1318
2. Kremkau F.W. Cancer therapy with ultrasound: a historical review. J Clin Ultrasound 7 4 (1979) 287-300
3. Lynn J.G., Zwemer R.L., and Chick A.J. The biological application of focused ultrasonic waves. Science 96 2483 (1942) 119-120
4. Ballantine Jr. H.T., Bell E., and Manlapaz J. Progress and problems in the neurological applications of focused ultrasound. J Neurosurg 17 (1960) 858-876
5. Ballantine Jr. H.T., Hueter T.F., Nauta W.J., et al. Focal destruction of nervous tissue by focused ultrasound: biophysical factors influencing its application. J Exp Med 104 3 (1956) 337-360
6. Barnard J.W., Fry W.J., Fry F.J., et al. Effects of high intensity ultrasound on the central nervous system of the cat. J Comp Neurol 103 3 (1955) 459-484
7. Fry F.J., Ades H.W., and Fry W.J. Production of reversible changes in the central nervous system by ultrasound. Science 127 3289 (1958) 83-84
8. Fry W.J. Intense ultrasound: a new tool for neurological research. J Ment Sci 100 418 (1954) 85-96
9. Fry W.J. Use of intense ultrasound in neurological research. Am J Phys Med 37 3 (1958) 143-147
10. Fry W.J. Intense ultrasound in investigations of the central nervous system. Adv Biol Med Phys 6 (1958) 281-348
11. Fry W.J., Barnard J.W., Fry E.J., et al. Ultrasonic lesions in the mammalian central nervous system. Science 122 3168 (1955) 517-518
12. Fry W.J., Barnard J.W., Fry F.J., et al. Ultrasonically produced localized selective lesions in the central nervous system. Am J Phys Med 34 3 (1955) 413-423
13. Fry W.J., Mosberg Jr. W.H., Barnard J.W., et al. Production of focal destructive lesions in the central nervous system with ultrasound. J Neurosurg 11 5 (1954) 471-478
14. Lele P.P. A simple method for production of trackless focal lesions with focused ultrasound: physical factors. J Physiol 160 (1962) 494-512
15. Lele P.P. Concurrent detection of the production of ultrasonic lesions. Med Biol Eng 4 5 (1966) 451-456
16. Lele P.P. Production of deep focal lesions by focused ultrasound-current status. Ultrasonics 5 (1967) 105-112
17. Wall P.D., Fry F.J., Stephens R., et al. Changes produced in the central nervous system by ultrasound. Science 114 2974 (1951) 686-687
18. Warwick R., and Pond J. Trackless lesions in nervous tissues produced by high intensity focused ultrasound (high-frequency mechanical waves). J Anat 102 Pt 3 (1968) 387-405
19. Fry F.J. Precision high intensity focusing ultrasonic machines for surgery. Am J Phys Med 37 3 (1958) 152-156
20. Burov A.K. High-intensity ultrasonic vibrations for action on animal and human malignant tumours. Dokl Akad Nauk SSSR 106 (1956) 239-241
21. Bamber J.C., and Hill C.R. Ultrasonic attenuation and propagation speed in mammalian tissues as a function of temperature. Ultrasound Med Biol 5 2 (1979) 149-157
22. Chivers R.C., and Hill C.R. Ultrasonic attenuation in human tissue. Ultrasound Med Biol 2 1 (1975) 25-29
23. Frizzell L.A. Threshold dosages for damage to mammalian liver by high intensity focused ultrasound. IEEE Trans Ultrason Ferroelectr Freq Control 35 5 (1988) 578-581
24. Goss S.A., Frizzell L.A., and Dunn F. Ultrasonic absorption and attenuation in mammalian tissues. Ultrasound Med Biol 5 2 (1979) 181-186
25. Parker K.J. Ultrasonic attenuation and absorption in liver tissue. Ultrasound Med Biol 9 4 (1983) 363-369
26. Fry F.J., and Johnson L.K. Tumor irradiation with intense ultrasound. Ultrasound Med Biol 4 4 (1978) 337-341
27. ter Haar G., Sinnett D., and Rivens I. High intensity focused ultrasound-a surgical technique for the treatment of discrete liver tumours. Phys Med Biol 34 11 (1989) 1743-1750
28. Zeiss E. Uber Linsenueranderungen An Heraus Genommenen Rinderlinsen durch Ultra-schallein Wirkung. Arch F Ophth 139 (1938) 301-322
29. Lavine O., Langenstrass K.H., Bowyer C.M., et al. Effects of ultrasonic waves on the refractive media of the eye. AMA Arch Ophthalmol 47 2 (1952) 204-219
30. Baum J., Singer S., and Jolesz F.A. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 219 1 (2001) 176-185
31. Purnell E.W. Ultrasonic biometry of the posterior ocular coats. Trans Am Ophthalmol Soc 78 (1980) 1027-1078
32. Purnell E.W., Sokollu A., and Holasek E. The production of focal chorioretinitis by ultrasound. A preliminary report. Am J Ophthalmol 58 (1964) 953-957
33. Purnell E.W., Sokollu A., Torchia R., et al. Focal chorioretinitis produced by ultrasound. Invest Ophthalmol 3 (1964) 657-664
34. Coleman D.J., Lizzi F.L., and Jakobiec F.A. Therapeutic ultrasound in the production of ocular lesions. Am J Ophthalmol 86 2 (1978) 185-192
35. Lizzi F.L., Coleman D.J., Driller J., et al. Experimental, ultrasonically induced lesions in the retina, choroid, and sclera. Invest Ophthalmol Vis Sci 17 4 (1978) 350-360
36. Lizzi F.L., Packer A.J., and Coleman D.J. Experimental cataract production by high frequency ultrasound. Ann Ophthalmol 10 7 (1978) 934-942
37. Coleman D.J., Lizzi F.L., Driller J., et al. Therapeutic ultrasound in the treatment of glaucoma. II. Clinical applications. Ophthalmology 92 3 (1985) 347-353
38. Coleman D.J., Lizzi F.L., Driller J., et al. Therapeutic ultrasound in the treatment of glaucoma. I. Experimental model. Ophthalmology 92 3 (1985) 339-346
39. Coleman D.J., Lizzi F.L., Silverman R.H., et al. Therapeutic ultrasound. Ultrasound Med Biol 12 8 (1986) 633-638
40. Lizzi F.L., Driller J., and Ostromogilsky M. Thermal model for ultrasonic treatment of glaucoma. Ultrasound Med Biol 10 3 (1984) 289-298
41. Clement G.T. Perspectives in clinical uses of high-intensity focused ultrasound. Ultrasonics 42 10 (2004) 1087-1093
42. Hindley J., Gedroyc W.M., Regan L., et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol 183 6 (2004) 1713-1719
43. Chan A.H., Fujimoto V.Y., Moore D.E., et al. In vivo feasibility of image-guided transvaginal focused ultrasound therapy for the treatment of intracavitary fibroids. Fertil Steril 82 3 (2004) 723-730
44. Chan A.H., Fujimoto V.Y., Moore D.E., et al. An image-guided high intensity focused ultrasound device for uterine fibroids treatment. Med Phys 29 11 (2002) 2611-2620
45. Vaezy S., Shi X., Martin R.W., et al. Real-time visualization of high-intensity focused ultrasound treatment using ultrasound imaging. Ultrasound Med Biol 27 1 (2001) 33-42
46. Parker K.J., Fu D., Graceswki S.M., et al. Vibration sonoelastography and the detectability of lesions. Ultrasound Med Biol 24 9 (1998) 1437-1447
47. Kallel F., Stafford R.J., Price R.E., et al. The feasibility of elastographic visualization of HIFU-induced thermal lesions in soft tissues. Image-guided high-intensity focused ultrasound. Ultrasound Med Biol 25 4 (1999) 641-647
48. Righetti R., Kallel F., Stafford R.J., et al. Elastographic characterization of HIFU-induced lesions in canine livers. Ultrasound Med Biol 25 7 (1999) 1099-1113
49. Souchon R., Rouvière O., Gelet A., et al. Visualisation of HIFU lesions using elastography of the human prostate in vivo: preliminary results. Ultrasound Med Biol 29 7 (2003) 1007-1015
50. Lizzi F.L., Muratore R., Deng C.X., et al. Radiation-force technique to monitor lesions during ultrasonic therapy. Ultrasound Med Biol 29 11 (2003) 1593-1605
51. Bercoff J., Pernot M., Tanter M., et al. Monitoring thermally-induced lesions with supersonic shear imaging. Ultrason Imaging 26 2 (2004) 71-84
52. Cheng S.Q., Zhou X.D., Tang Z.Y., et al. High-intensity focused ultrasound in the treatment of experimental liver tumour. J Cancer Res Clin Oncol 123 4 (1997) 219-223
53. Prat F., Centarti M., Sibille A., et al. Extracorporeal high-intensity focused ultrasound for VX2 liver tumors in the rabbit. Hepatology 21 3 (1995) 832-836
54. Sibille A., Prat F., Chapelon J.Y., et al. Extracorporeal ablation of liver tissue by high-intensity focused ultrasound. Oncology 50 5 (1993) 375-379
55. Yang R., Reilly C.R., Rescorla F.J., et al. High-intensity focused ultrasound in the treatment of experimental liver cancer. Arch Surg 126 8 (1991) 1002-1009 [discussion: 1009-10]
56. Yang R., Sanghvi N.T., Rescorla F.J., et al. Liver cancer ablation with extracorporeal high-intensity focused ultrasound. Eur Urol 23 Suppl 1 (1993) 17-22
57. Wu F., Wang Z.B., Chen W.Z., et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem 11 3-4 (2004) 149-154
58. Wu F., Wang Z.B., Chen W.Z., et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 235 2 (2005) 659-667
59. Wu F., Chen W.Z., Bai J., et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol 27 8 (2001) 1099-1106
60. Illing R.O., Kennedy J.E., Wu F., et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer 93 8 (2005) 890-895
61. Kennedy J.E., ter Haar G.R., Wu F., et al. Contrast-enhanced ultrasound assessment of tissue response to high-intensity focused ultrasound. Ultrasound Med Biol 30 6 (2004) 851-854
62. Kennedy J.E., Wu F., ter Haar G.R., et al. High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics 42 1-9 (2004) 931-935
63. Bihrle R., Foster R.S., Sanghvi N.T., et al. High-intensity focused ultrasound in the treatment of prostatic tissue. Urology 43 2 Suppl (1994) 21-26
64. Foster R.S., Bihrle R., Sanghvi N.T., et al. High-intensity focused ultrasound in the treatment of prostatic disease. Eur Urol 23 Suppl 1 (1993) 29-33
65. Gelet A., Chapelon J.Y., Margonari J., et al. High-intensity focused ultrasound experimentation on human benign prostatic hypertrophy. Eur Urol 23 Suppl 1 (1993) 44-47
66. Ebert T., Graefen M., Miller S., et al. High-intensity focused ultrasound (HIFU) in the treatment of benign prostatic hyperplasia (BPH). Keio J Med 44 4 (1995) 146-149
67. Nakamura K., Baba S., Fukazawa R., et al. Treatment of benign prostatic hyperplasia with high intensity focused ultrasound: an initial clinical trial in Japan with magnetic resonance imaging of the treated area. Int J Urol 2 3 (1995) 176-180
68. Nakamura K., Baba S., Saito S., et al. High-intensity focused ultrasound energy for benign prostatic hyperplasia: clinical response at 6 months to treatment using Sonablate 200. J Endourol 11 3 (1997) 197-201
69. Sanghvi N.T., Foster R.S., Bihrle R., et al. Noninvasive surgery of prostate tissue by high intensity focused ultrasound: an updated report. Eur J Ultrasound 9 1 (1999) 19-29
70. Sullivan L., Casey R.W., Pommerville P.J., et al. Canadian experience with high intensity focused ultrasound for the treatment of BPH. Can J Urol 6 3 (1999) 799-805
71. Uchida T., Muramoto M., Kyunou H., et al. Clinical outcome of high-intensity focused ultrasound for treating benign prostatic hyperplasia: preliminary report. Urology 52 1 (1998) 66-71
72. Uchida T., Yokoyama E., Iwamura M., et al. High intensity focused ultrasound for benign prostatic hyperplasia. Int J Urol 2 3 (1995) 181-185
73. Madersbacher S., Schatzl G., Djavan B., et al. Long-term outcome of transrectal high-intensity focused ultrasound therapy for benign prostatic hyperplasia. Eur Urol 37 6 (2000) 687-694
74. Kour N.W. Minimally invasive surgery for benign prostatic hyperplasia-a review. Ann Acad Med Singap 24 4 (1995) 619-626
75. Mulligan E.D., Lynch T.H., Mulvin D., et al. High-intensity focused ultrasound in the treatment of benign prostatic hyperplasia. Br J Urol 79 2 (1997) 177-180
76. Hegarty N.J., and Fitzpatrick J.M. High intensity focused ultrasound in benign prostatic hyperplasia. Eur J Ultrasound 9 1 (1999) 55-60
77. Chapelon J.Y., Margonari J., Vernier F., et al. In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327. Cancer Res 52 22 (1992) 6353-6357
78. Madersbacher S., Pedevilla M., Vingers L., et al. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 55 15 (1995) 3346-3351
79. Beerlage H.P., Pedevilla M., Vingers L., et al. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology 54 2 (1999) 273-277
80. Chapelon J.Y., Ribault M., Vernier F., et al. Treatment of localised prostate cancer with transrectal high intensity focused ultrasound. Eur J Ultrasound 9 1 (1999) 31-38
81. Chaussy C., and Thuroff S. High-intensity focused ultrasound in prostate cancer: results after 3 years. Mol Urol 4 3 (2000) 179-182
82. Chaussy C., and Thuroff S. Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J Endourol 15 4 (2001) 437-440 [discussion: 447-8]
83. Chaussy C., and Thuroff S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 4 3 (2003) 248-252
84. Gelet A., Chapelon J.Y., Bouvier R., et al. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J Endourol 14 6 (2000) 519-528
85. Gelet A., Chapelon J.Y., Bouvier R., et al. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol 40 2 (2001) 124-129
86. Gelet A., Chapelon J.Y., Bouvier R., et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol 29 2 (1996) 174-183
87. Madersbacher S., Kratzik C., and Marberger M. Prostatic tissue ablation by transrectal high intensity focused ultrasound: histological impact and clinical application. Ultrason Sonochem 4 2 (1997) 175-179
88. Rebillard X., Gelet A., Davin J.L., et al. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer. J Endourol 19 6 (2005) 693-701
89. Thuroff S., Chaussy C., Vallancien G., et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 17 8 (2003) 673-677
90. Uchida T. High-intensity focused ultrasound for localized prostate cancer. Nippon Rinsho 63 2 (2005) 345-349
91. Uchida T., Sanghvi N.T., Gardner T.A., et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. Urology 59 3 (2002) 394-398 [discussion: 398-9]
92. Vallancien G., Prapotnich D., Cathelineau X., et al. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. J Urol 171 6 Pt 1 (2004) 2265-2267
93. Blana A., Walter B., Rogenhofer S., et al. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 63 2 (2004) 297-300
94. Pickles T., Goldenberg L., and Steinhoff G. Technology review: high-intensity focused ultrasound for prostate cancer. Can J Urol 12 2 (2005) 2593-2597
95. Beerlage H.P., Thüroff S., Madersbacher S., et al. Current status of minimally invasive treatment options for localized prostate carcinoma. Eur Urol 37 1 (2000) 2-13
96. Colombel M., and Gelet A. Principles and results of high-intensity focused ultrasound for localized prostate cancer. Prostate Cancer Prostatic Dis 7 4 (2004) 289-294
97. Madersbacher S., and Marberger M. High-energy shockwaves and extracorporeal high-intensity focused ultrasound. J Endourol 17 8 (2003) 667-672
98. Saleh K.Y., and Smith N.B. A 63 element 1.75 dimensional ultrasound phased array for the treatment of benign prostatic hyperplasia. Biomed Eng Online 4 1 (2005) 39
99. Hacker A., Köhrmann K.U., Back W., et al. Extracorporeal application of high-intensity focused ultrasound for prostatic tissue ablation. BJU Int 96 1 (2005) 71-76
100. Hynynen K., Freund W.R., Cline H.S., et al. A clinical, noninvasive, MR imaging-monitored ultrasound surgery method. Radiographics 16 1 (1996) 185-195
101. Hynynen K., Pomeroy O., Smith D.N., et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 219 1 (2001) 176-185
102. Huber P.E., Jenne J.W., Rastert R., et al. A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery. Cancer Res 61 23 (2001) 8441-8447
103. Gianfelice D., Khiat A., Amara M., et al. MR imaging-guided focused ultrasound surgery of breast cancer: correlation of dynamic contrast-enhanced MRI with histopathologic findings. Breast Cancer Res Treat 82 2 (2003) 93-101
104. Zippel D.B., and Papa M.Z. The use of MR imaging guided focused ultrasound in breast cancer patients: a preliminary phase one study and review. Breast Cancer 12 1 (2005) 32-38
105. Wu F., Wang Z.B., Zhu H., et al. Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer. Breast Cancer Res Treat 92 1 (2005) 51-60
106. Adams J.B., Moore R.G., Anderson J.H., et al. High-intensity focused ultrasound ablation of rabbit kidney tumors. J Endourol 10 1 (1996) 71-75
107. Chapelon J.Y., Margonari J., Theillère Y., et al. Effects of high-energy focused ultrasound on kidney tissue in the rat and the dog. Eur Urol 22 2 (1992) 147-152
108. Damianou C. In vitro and in vivo ablation of porcine renal tissues using high-intensity focused ultrasound. Ultrasound Med Biol 29 9 (2003) 1321-1330
109. Damianou C. MRI monitoring of the effect of tissue interfaces in the penetration of high intensity focused ultra sound in kidney in vivo. Ultrasound Med Biol 30 9 (2004) 1209-1215
110. Damianou C., Pavlou M., Velev O., et al. High intensity focused ultrasound ablation of kidney guided by MRI. Ultrasound Med Biol 30 3 (2004) 397-404
111. Daum D.R., Smith N.B., King R., et al. In vivo demonstration of noninvasive thermal surgery of the liver and kidney using an ultrasonic phased array. Ultrasound Med Biol 25 7 (1999) 1087-1098
112. Frizzell L.A., Linke C.A., Carstensen E.L., et al. Thresholds for focal ultrasonic lesions in rabbit kidney, liver, and testicle. IEEE Trans Biomed Eng 24 4 (1977) 393-396
113. Watkin N.A., Morris S.B., Rivens I.H., et al. High-intensity focused ultrasound ablation of the kidney in a large animal model. J Endourol 11 3 (1997) 191-196
114. Susani M., Madersbacher S., Kratzik C., et al. Morphology of tissue destruction induced by focused ultrasound. Eur Urol 23 Suppl 1 (1993) 34-38
115. Kohrmann K.U., Michel M.S., Gaa J., et al. High intensity focused ultrasound as noninvasive therapy for multilocal renal cell carcinoma: case study and review of the literature. J Urol 167 6 (2002) 2397-2403
116. Roberts W.W. Focused ultrasound ablation of renal and prostate cancer: current technology and future directions. Urol Oncol 23 5 (2005) 367-371
117. Trabulsi E.J., Kalra P., and Gomella L.G. New approaches to the minimally invasive treatment of kidney tumors. Cancer J 11 1 (2005) 57-63
118. Chartier-Kastler E., Chopin D., and Vallancien G. The effects of focused extracorporeal pyrotherapy on a human bladder tumor cell line (647 V). J Urol 149 3 (1993) 643-647
119. Vallancien G., Chartier-Kastler E., Bataille N., et al. Focused extracorporeal pyrotherapy. Eur Urol 23 Suppl 1 (1993) 48-52
120. Vallancien G., Chartier-Kastler E., Chopin D., et al. Focussed extracorporeal pyrotherapy: experimental results. Eur Urol 20 3 (1991) 211-219
121. Vallancien G., Chopin D., Davila C., et al. Focused extracorporeal pyrotherapy. Initial experimental results. Prog Urol 1 1 (1991) 149-153
122. Vallancien G., Veillon B., Charton M., et al. Can transabdominal ultrasonography of the bladder replace cystoscopy in the followup of superficial bladder tumors?. J Urol 136 1 (1986) 32-34
123. Wang G.M., Yang Y.F., Sun L.A., et al. [An experimental study on high intensity focused ultrasound combined with mitomycin treatment of bladder tumor]. Zhonghua Wai Ke Za Zhi 41 12 (2003) 897-900 [ in Chinese]
124. Watkin N.A., Morris S.B., Rivens I.H., et al. A feasibility study for the non-invasive treatment of superficial bladder tumours with focused ultrasound. Br J Urol 78 5 (1996) 715-721
125. Vallancien G., Harouni M., Guillonneau B., et al. Ablation of superficial bladder tumors with focused extracorporeal pyrotherapy. Urology 47 2 (1996) 204-207
126. Hoshi S., Orikasa S., Kuwahara M., et al. Shock wave and THP-adriamycin for treatment of rabbit's bladder cancer. Jpn J Cancer Res 83 3 (1992) 248-250
127. Hoshi S., Orikasa S., Kuwahara M., et al. High energy underwater shock wave treatment on implanted urinary bladder cancer in rabbits. J Urol 146 2 (1991) 439-443
128. Hosi S., Orikasa S., Kuwahara M., et al. The effect of high-energy underwater shock waves on implanted urinary bladder cancer in rabbits. Jpn J Cancer Res 81 4 (1990) 317-319
129. Uchida T., Ohori M., and Egawa S. [Minimally invasive therapy for bladder and prostate cancer]. Gan To Kagaku Ryoho 28 8 (2001) 1094-1098 [in Japanese]
130. Hynynen K., Colucci V., Chung A., et al. Noninvasive arterial occlusion using MRI-guided focused ultrasound. Ultrasound Med Biol 22 8 (1996) 1071-1077
131. Vaezy S., Martin R., and Crum L. High intensity focused ultrasound: a method of hemostasis. Echocardiography 18 4 (2001) 309-315
132. Martin R.W., Vaezy S., Kaczkowski P., et al. Hemostasis of punctured vessels using Doppler-guided high-intensity ultrasound. Ultrasound Med Biol 25 6 (1999) 985-990
133. Vaezy S., Marti R., Mourad P., et al. Hemostasis using high intensity focused ultrasound. Eur J Ultrasound 9 1 (1999) 79-87
134. Vaezy S., Martin R., Kaczkowski P., et al. Use of high-intensity focused ultrasound to control bleeding. J Vasc Surg 29 3 (1999) 533-542
135. Vaezy S., Martin R., Keilman G., et al. Control of splenic bleeding by using high intensity ultrasound. J Trauma 47 3 (1999) 521-525
136. Vaezy S., Martin R., Schmiedl U., et al. Liver hemostasis using high-intensity focused ultrasound. Ultrasound Med Biol 23 9 (1997) 1413-1420
137. Vaezy S., Martin R., Yaziji H., et al. Hemostasis of punctured blood vessels using high-intensity focused ultrasound. Ultrasound Med Biol 24 6 (1998) 903-910
138. Noble M.L., Vaezy S., Keshavarzi A., et al. Spleen hemostasis using high-intensity ultrasound: survival and healing. J Trauma 53 6 (2002) 1115-1120
139. Vaezy S., Noble M.L., Keshavarzi A., et al. Liver hemostasis with high-intensity ultrasound: repair and healing. J Ultrasound Med 23 2 (2004) 217-225
140. Zderic V., Keshavarzi A., Noble M.L., et al. Hemorrhage control in arteries using high-intensity focused ultrasound: a survival study. Ultrasonics 44 1 (2006) 46-53
141. Cornejo C.J., Vaezy S., Jurkovich G.J., et al. High-intensity ultrasound treatment of blunt abdominal solid organ injury: an animal model. J Trauma 57 1 (2004) 152-156
142. Deng C.X., Dogra V., Exner A.A., et al. A feasibility study of high intensity focused ultrasound for liver biopsy hemostasis. Ultrasound Med Biol 30 11 (2004) 1531-1537
143. Keshavarzi A., Vaezy S., Noble M.L., et al. Treatment of uterine leiomyosarcoma in a xenograft nude mouse model using high-intensity focused ultrasound: a potential treatment modality for recurrent pelvic disease. Gynecol Oncol 86 3 (2002) 344-350
144. Keshavarzi A., Vaezy S., Noble M.L., et al. Treatment of uterine fibroid tumors in an in situ rat model using high-intensity focused ultrasound. Fertil Steril 80 Suppl 2 (2003) 61-67
145. Vaezy S., Fujimoto V.Y., Walker C., et al. Treatment of uterine fibroid tumors in a nude mouse model using high-intensity focused ultrasound. Am J Obstet Gynecol 183 1 (2000) 6-11
146. Jolesz F.A., Hynynen K., McDannold N., et al. MR imaging-controlled focused ultrasound ablation: a noninvasive image-guided surgery. Magn Reson Imaging Clin N Am 13 3 (2005) 545-560
147. Stewart E.A., Gedroyc W.M., Tempany C.M., et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 189 1 (2003) 48-54
148. Tempany C.M., Stewart E.A., McDannold N., et al. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 226 3 (2003) 897-905
149. Jacobs M.A., Herskovits E.H., and Kim H.S. Uterine fibroids: diffusion-weighted MR imaging for monitoring therapy with focused ultrasound surgery-preliminary study. Radiology 236 1 (2005) 196-203
150. Hynynen K., and Jolesz F.A. Demonstration of potential noninvasive ultrasound brain therapy through an intact skull. Ultrasound Med Biol 24 2 (1998) 275-283
151. Sun J., and Hynynen K. The potential of transskull ultrasound therapy and surgery using the maximum available skull surface area. J Acoust Soc Am 105 4 (1999) 2519-2527
152. Tanter M., Thomas J.L., and Fink M. Focusing and steering through absorbing and aberrating layers: application to ultrasonic propagation through the skull. J Acoust Soc Am 103 5 Pt 1 (1998) 2403-2410
153. Clement G.T., and Hynynen K. Correlation of ultrasound phase with physical skull properties. Ultrasound Med Biol 28 5 (2002) 617-624
154. Clement G.T., and Hynynen K. A non-invasive method for focusing ultrasound through the human skull. Phys Med Biol 47 8 (2002) 1219-1236
155. Aubry J.F., Tanter M., Pernot M., et al. Experimental demonstration of noninvasive transskull adaptive focusing based on prior computed tomography scans. J Acoust Soc Am 113 1 (2003) 84-93
156. Aarnio J., Clement G.T., and Hynynen K. A new ultrasound method for determining the acoustic phase shifts caused by the skull bone. Ultrasound Med Biol 31 6 (2005) 771-780
157. Patrick J.T., Nolting M.N., Goss S.A., et al. Ultrasound and the blood-brain barrier. Adv Exp Med Biol 267 (1990) 369-381
158. Mesiwala A.H., Farrell L., Wenzel H.J., et al. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med Biol 28 3 (2002) 389-400
159. Hynynen K., McDannold N., Vykhodtseva N., et al. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220 3 (2001) 640-646
160. Hynynen K., McDannold N., Sheikov N.A., et al. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 24 1 (2005) 12-20
161. Velling V.A., and Shkliaruk S.P. [Modulation of the functional state of the brain using focused ultrasound]. Fiziols Zh SSSR Im I M Sechenova 73 6 (1987) 708-714 [in Russian]
162. Velling V.A., and Shklyaruk S.P. Modulation of the functional state of the brain with the aid of focused ultrasonic action. Neurosci Behav Physiol 18 5 (1988) 369-375
163. Bednarski M.D., Lee J.W., Callstrom M.R., et al. In vivo target-specific delivery of macromolecular agents with MR-guided focused ultrasound. Radiology 204 1 (1997) 263-268
164. Yuh E.L., Shulman S.G., Mehta S.A., et al. Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model. Radiology 234 2 (2005) 431-437
165. Zhai B.J., Shao Z.Y., Wu F., et al. [Reversal of multidrug resistance of human hepatocarcinoma HepG2/Adm cells by high intensity focused ultrasound]. Ai Zheng 22 12 (2003) 1284-1288 [in Chinese]
166. Kinoshita M., and Hynynen K. A novel method for the intracellular delivery of siRNA using microbubble-enhanced focused ultrasound. Biochem Biophys Res Commun 335 2 (2005) 393-399
167. Miller D.L., Pislaru S.V., and Greenleaf J.E. Sonoporation: mechanical DNA delivery by ultrasonic cavitation. Somat Cell Mol Genet 27 1-6 (2002) 115-134
168. Rapoport N. Combined cancer therapy by micellar-encapsulated drug and ultrasound. Int J Pharm 277 1-2 (2004) 155-162
169. Rapoport N.Y., Christensen D.A., Fain H.D., et al. Ultrasound-triggered drug targeting of tumors in vitro and in vivo. Ultrasonics 42 1-9 (2004) 943-950
170. Sheikov N., McDannold N., Vykhodtseva N., et al. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol 30 7 (2004) 979-989
171. Lizzi F.L., Deng C.X., Lee P., et al. A comparison of ultrasonic beams for thermal treatment of ocular tumors. Eur J Ultrasound 9 1 (1999) 71-78